Alexandre Ferrand

Current assignment @ a Pharmaceutical Vaccines Company (Wavre, BE) : Global Quality Portfolio, Program Management & PMO deployment

R&D Asset Management, Process Excellence, Organizational Effectiveness and Innovation Process Improvement: within a commitment in a project team, participate to the analysis and assessment of potential improvement within R&D activities followed by a project definition. Further operational implementation of risk management, knowledge capitalization, projects’ prioritization and KPI tools and personal behavior changes together with hosting company’s actors and interfacing people.

Manage the Organic Electronic Platform Patent portfolio build in-house and within collaborations: Drafting, assessment, filing and prosecution of in-house and external (joined and founded) collaborations patents mostly at the European and United States patent offices under the supervision of a senior patent attorney.

- Design synthesis and development of new materials for organic electronic applications: manage design, synthesis and early development of new molecules both monomers and single molecules in tight collaboration with the products evaluation team, external associates universities and incorporated companies. Research strategy lead to improve molecule’s performances together with synthesis early development linked to a future larger scale production. - Synthesis development of fluorinated intermediates

Studies on electron transport through DNA and enzymes : the synthesis of nucleosides and oligonucleotides coupled to light-activated electron injectors and/or porphyrin-type electron traps allow the study of electron transport in DNA and enzymes.

Construction of the biaryl Vancomycin array via Bergman cyclisation: an innovating route to access to the Vancomycin biaryl array via stereocontroled Bergman cyclisation has being developed. The synthesis of the chiral tether linked enediynes targets involved the use of assorted organic reactions.

Group of Prof. Paul Müller Enantioselective desymmetrisation of meso 1,3-dioxanes, 1,3-dioxolanes and gem-diacetates: The desymmetrisation reactions of meso 2-substituted 1,3-dioxanes, 1,3-dioxolanes and gem-diacetates by nucleophilic attack were studied.

Pr. Marc Lemaire Synthesis of optically pure N,O ligands and their applications in asymmetric catalysis: syntheses of new C2 symmetric ligands containing the chiral N,N-dimethyl-1,2-diphenylethylene-diamine moiety were developed. Asymmetric iridium-catalyzed hydrogenation of acetophenone was achieve